| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $1.2M | +1096.2% | +2491.7% |
| Operating Income | -$1.9M | +5.3% | -577.4% |
| Interest Expense | $517K | — | — |
| Net Income | -$2.0M | +8.2% | -438.1% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $103K | -87.3% | -58.6% |
| Total Assets | $104K | -87.2% | -58.4% |
| Current Liabilities | $5.5M | +13.4% | -4.3% |
| Total Liabilities | $5.5M | +13.4% | -4.3% |
| Stockholders' Equity | -$5.4M | -33.4% | +1.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | — |
| Financing Cash Flow | $3.3M | — | — |
| — |